UK cost agency queries value of $700,000-a-year Alexion drug
0
LONDON (Reuters) - An enzyme treatment from Alexion Pharmaceuticals costing 491,992 pounds ($704,630) a year may be worth using in babies with a rare disorder but does not represent good value for all patients, Britain's healthcare cost watchdog said.